Company / Inventory
Neogen Inventory History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$190.9M
FY2025
5-year range
$100.7M / $190.9M
FY2021-FY2025
Trend
+0.8%
vs FY2024
Sector context
#61 of 118
Health Care
What the data says
At $191M, Neogen's inventory ranks #61 of 118 in the Health Care sector. Inventory has increased for 9 consecutive years, from $64M in FY2016 to $191M in FY2025.
Based on SEC 10-K filings.
$191M in FY2025 with a 5-year CAGR of +15.0%.
Improved from $134M to $191M over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- +16.0%
- 5-Year CAGR
- +15.0%
- 10-Year CAGR
- -
Sector benchmark
#61 of 118 in Health CareTop 52% of 118This company $190.9M Sector average $1.4B
▼
-86.5% below sector average
Key checks
Key Insights
- Neogen's inventory has grown for 9 consecutive years.
- 5-year CAGR of +15.0%, indicating consistent growth.
- In FY2025, inventory increased 0.8% year-over-year.
- Ranks #61 out of 118 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.59 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $190.9M | +0.8% |
| FY2024 | $189.3M | +41.4% |
| FY2023 | $133.8M | +9.4% |
| FY2022 | $122.3M | +21.5% |
| FY2021 | $100.7M | +5.9% |
| FY2020 | $95.1M | +10.5% |
| FY2019 | $86.0M | +13.1% |
| FY2018 | $76.0M | +3.9% |
| FY2017 | $73.1M | +13.6% |
| FY2016 | $64.4M | +24.7% |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026